As Annual Recurring Revenue Accelerates, CrowdStrike Buy?
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Finding the right no fee cash back card can enhance your savings. Discover which card suits your financial habits best.
26,735 articlesCrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
As AI workloads surge, Celestica could play a pivotal role in data-center hardware. This guide breaks down the busine...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
Celebrity splits reveal how money moves when two high earners part ways. This article translates those moments into p...
Rising tensions with Iran are driving new concerns about sleeper-cell threats on U.S. soil. Defense experts warn of m...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
When big funds hold IonQ, retail investors often assume a sure bet. The reality is more nuanced: ownership data refle...
A major fund reported a sizeable exit from an offshore energy stake, triggering a review of how investors manage risk...
Apple’s shares tumbled after WWDC-style AI updates raised questions about iPhone upgrades and monetization. This guid...
Novo Nordisk slashing prices is drawing attention from investors who wonder how a price cut could actually lift the s...